Purpose: Despite the availability of new drugs, many patients with acute myeloid leukemia (AML) do not achieve remission and outcomes remain poor. Venetoclax is a promising new therapy approved for use in combination with a hypomethylating agent or with low dose cytarabine for the treatment of newly diagnosed older AML patients or those ineligible for intensive chemotherapy….
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
